The functional role of high expression levels of CLDND1 in a normal central nervous system and in cerebrovascular disease is not known, and further analysis is needed to determine the effects of gefitinib treatment on the brain tissue by suppressing CLDND1 expression. Here, CLDND1 is linked to cerebrovascular disorder.